Sera Prognostics Financials

Earnings View

Profitability View

Liquidity View

Fundamentals View

Competition View

Sera Prognostics Stock Summary

Sera Prognostics competes with Fonar, Burning Rock, Exagen, Sotera Health, and Psychemedics. Sera Prognostics, Inc., a womens health diagnostic company, discovers, develops, and commercializes biomarker tests for improving pregnancy outcomes. The company was incorporated in 2008 and is headquartered in Salt Lake City, Utah. Sera Prognostics operates under Diagnostics Research classification in the United States and is traded on NASDAQ Exchange. It employs 113 people.

Sera Prognostics Key Financial Ratios

Sera Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Sera Prognostics's current stock value. Our valuation model uses many indicators to compare Sera Prognostics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Sera Prognostics competition to find correlations between indicators driving Sera Prognostics's intrinsic value. More Info.Sera Prognostics is rated fifth in return on equity category among its peers. It is rated below average in return on asset category among its peers . At present, Sera Prognostics' Return On Equity is projected to slightly decrease based on the last few years of reporting. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Sera Prognostics' earnings, one of the primary drivers of an investment's value.

Sera Prognostics Systematic Risk

Today, most investors in Sera Prognostics Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Sera Prognostics' growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Sera Prognostics growth as a starting point in their analysis.

Along with financial statement analysis, the daily predictive indicators of Sera Prognostics help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Sera Prognostics. We use our internally-developed statistical techniques to arrive at the intrinsic value of Sera Prognostics based on widely used predictive technical indicators. In general, we focus on analyzing Sera Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Sera Prognostics's daily price indicators and compare them against related drivers.

When running Sera Prognostics' price analysis, check to measure Sera Prognostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sera Prognostics is operating at the current time. Most of Sera Prognostics' value examination focuses on studying past and present price action to predict the probability of Sera Prognostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sera Prognostics' price. Additionally, you may evaluate how the addition of Sera Prognostics to your portfolios can decrease your overall portfolio volatility.